Literature DB >> 17309777

Iron ions and haeme modulate the binding properties of complement subcomponent C1q and of immunoglobulins.

J D Dimitrov1, L T Roumenina, V R Doltchinkova, T L Vassilev.   

Abstract

The complement system and circulating antibodies play a major role in the defence against infection. They act at the sites of inflammation, where the harsh microenvironment and the oxidative stress lead to the release of free iron ions and haeme. The aim of this study was to analyse the consequences of the exposure of C1q and immunoglobulins to iron ions or haeme. The changes in target recognition by C1q and in the rheumatoid factor activity of the immunoglobulins were investigated. The exposure of C1q to ferrous ions increased its binding to IgG and to IgM. In contrast, haeme inhibited C1q binding to all studied targets, especially to IgG1 and C-reactive protein. Thus, the haeme released as a result of tissue damage and oxidative stress may act as a negative feedback regulator of an inappropriate complement triggering as seen in ischaemia-reperfusion tissue injury. The results also show that iron ions and haeme were able to reveal rheumatoid factor activity of IgG. The modulation of the C1q-target binding as well as the revealing of rheumatoid factor activity of IgG by exposure to redox-active agents released at the sites of inflammation may have important consequences for the understanding of the immunopathological mechanisms of inflammatory and autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17309777     DOI: 10.1111/j.1365-3083.2006.01893.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

1.  Iron-induced necrotic brain cell death in rats with different aerobic capacity.

Authors:  Mingzhe Zheng; Hanjian Du; Wei Ni; Lauren G Koch; Steven L Britton; Richard F Keep; Guohua Xi; Ya Hua
Journal:  Transl Stroke Res       Date:  2015-02-05       Impact factor: 6.829

2.  P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4/heme-dependent manner.

Authors:  Nicolas S Merle; Romain Paule; Juliette Leon; Marie Daugan; Tania Robe-Rybkine; Victoria Poillerat; Carine Torset; Véronique Frémeaux-Bacchi; Jordan D Dimitrov; Lubka T Roumenina
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-08       Impact factor: 11.205

3.  Autoimmune reactivity of IgM acquired after oxidation.

Authors:  Jasna Omersel; Ivica Avberšek-Lužnik; Pegi Ahlin Grabnar; Tanja Kveder; Blaž Rozman; Borut Božič
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

4.  Heme interacts with c1q and inhibits the classical complement pathway.

Authors:  Lubka T Roumenina; Maria Radanova; Boris P Atanasov; Krastio T Popov; Srinivas V Kaveri; Sébastien Lacroix-Desmazes; Véronique Frémeaux-Bacchi; Jordan D Dimitrov
Journal:  J Biol Chem       Date:  2011-03-22       Impact factor: 5.157

Review 5.  Complement inhibitors to treat IgM-mediated autoimmune hemolysis.

Authors:  Diana Wouters; Sacha Zeerleder
Journal:  Haematologica       Date:  2015-11       Impact factor: 9.941

6.  Functional Changes of Therapeutic Antibodies upon Exposure to Pro-Oxidative Agents.

Authors:  Maxime Lecerf; Robin Lacombe; Alexia Kanyavuz; Jordan D Dimitrov
Journal:  Antibodies (Basel)       Date:  2022-02-02

7.  Complement factors C1q, C3 and C5 in brain and serum of mice with cerebral malaria.

Authors:  Peter Lackner; Christian Hametner; Ronny Beer; Christoph Burger; Gregor Broessner; Raimund Helbok; Cornelia Speth; Erich Schmutzhard
Journal:  Malar J       Date:  2008-10-10       Impact factor: 2.979

8.  Iron Heterogeneity in Early Active Multiple Sclerosis Lesions.

Authors:  Mylyne Tham; Josa M Frischer; Stephen D Weigand; Patrick D Fitz-Gibbon; Samuel M Webb; Yong Guo; Reginald C Adiele; Christopher A Robinson; Wolfgang Brück; Hans Lassmann; Kendra L Furber; M Jake Pushie; Joseph E Parisi; Claudia F Lucchinetti; Bogdan F Popescu
Journal:  Ann Neurol       Date:  2020-12-19       Impact factor: 10.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.